GlassScriptPhysician profile
Christopher L Paris
NPI 1902953888
$36,569.61
in general payments reported to CMS, 2019-2025
39 companies · $546 in 2025
The $546 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $15K · 2021: $1,162 · 2022: $901 · 2023: $1,494 · 2024: $315 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,355.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $10,848.80 | 2019-2021 | |
| Cardiovascular Systems INC. | $8,988.59 | 2019-2023 | Diamondback Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,022.28 | 2019-2021 | |
| Inari Medical, INC. | $3,040.09 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $2,893.24 | 2019-2020 | |
| Abiomed | $1,128.89 | 2019-2025 | |
| Medtronic, INC. | $863.21 | 2021-2023 | Resolute Onyx, Corevalve Evolut R, Abre |
| Abbott Laboratories | $800.33 | 2019-2025 | Diamondback Coronary, Diamondback Peripheral, Cardiomems |
| Novartis Pharmaceuticals Corporation | $610.95 | 2019-2025 | |
| Amgen INC. | $447.23 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $400.60 | 2019-2025 | Farxiga |
| Penumbra, INC. | $284.01 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $244.08 | 2019-2022 | |
| Cardiva Medical, INC. | $231.56 | 2019-2022 | |
| Pfizer INC. | $228.19 | 2020-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $190.47 | 2023 | Prodigy Catheter, Symphony Catheter |
| Esperion Therapeutics, INC. | $110.05 | 2020-2025 | Nexletol |
| Cvrx, INC. | $103.04 | 2022 | |
| Glaxosmithkline, LLC. | $103.01 | 2020-2025 | Nucala, Trelegy Ellipta |
| Livanova USA, INC. | $99.04 | 2019 | |
| Merck Sharp & Dohme LLC | $97.63 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.97 | 2020-2025 | Jardiance |
| Philips North America LLC | $84.33 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $81.89 | 2019 | |
| Angiodynamics, INC. | $72.28 | 2023 | Auryon Laser System 100-120 Vac |
| Regeneron Healthcare Solutions, INC. | $71.59 | 2019 | |
| Novo Nordisk INC | $64.27 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Boston Scientific Corporation | $54.70 | 2020-2021 | |
| Terumo Medical Corporation | $46.29 | 2019-2023 | Angio-Seal |
| Bayer Healthcare Pharmaceuticals INC. | $42.19 | 2021-2022 | |
| Amarin Pharma, INC. | $34.68 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.50 | 2019-2025 | Camzyos |
| Itamar Medical INC | $27.50 | 2022-2024 | Watchpatone |
| Arbor Pharmaceuticals, INC. | $26.62 | 2019-2021 | |
| Inspire Medical Systems, INC. | $24.15 | 2025 | Inspire |
| Biotronik INC. | $23.34 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $20.53 | 2019 | |
| Ekos Corporation | $20.41 | 2019 | |
| Cook Medical LLC | $19.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Paris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.